LGC Acquires Maine Standards Company
LGC (London, UK) has announced its acquisition of Maine Standards Company (Cumberland Foreside, Maine, USA).
LGC (London, UK) has announced its acquisition of Maine Standards Company (Cumberland Foreside, Maine, USA). A leading provider of calibration verification materials in the US, Maine Standards Company bolsters LGC’s portfolio of reference materials and proficiency testing schemes available for the clinical market.
Euan O’Sullivan, Managing Director of LGC’s Standards Divison, expressed his delight in welcoming the Maine based company to LGC, and commented “Our two organizations represent a highly complementary commercial and cultural fit, with a common commitment to developing products of the very highest quality for the benefit of our customers. We look forward to working with Maine Standards Company to complete its leading portfolio of calibration verification materials for the US market, whilst using our global network to expand sales of these products internationally.”
Maine Standards Company will continue to operate from its recently opened facility near Portland, Maine. Tom Happe, Founder and President of Maine Standards Company, hoped the union of the two companies capabilities would ease the transition of Maine Standards Company into the global market and address growing interest in their services from overseas.
Both companies hope the combination of their respective analytical capabilities will lead to the development of new products for their mutual customers.
For more information please visit www.lgcgroup.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
